# Bay98-7196, Dose Finding / POC Study

> **NCT02203331** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 319 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Levonorgestrel
- **DRUG:** Anastrozole
- **DRUG:** Lupron / Leuprolide acetate

## Key facts

- **NCT ID:** NCT02203331
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-16
- **Primary completion:** 2016-10-24
- **Final completion:** 2016-10-24
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02203331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02203331, "Bay98-7196, Dose Finding / POC Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02203331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*